Our FAP‐CAR‐T cell products contain ~75% CAR‐negative T cells, leading us to hypothesise that CAR‐T cells may secrete cytokines to mobilise the non‐transduced T cells into the antitumor response after activation by FAP‐expressing tumor cells (Figure 5a). Here, FAP is linked to neoplasm.